BIOCELTIX S.A. ZY -10 Financial Flexibility Index
BIOCELTIX S.A. ZY -10 financial flexibility index. BIOCELTIX S.A. ZY -10 (XI3) has a Financial Flexibility Index of -1.69x as of December 2025. Free cash flow of €-3.99 Million (operating CF €-4.54 Million minus capex €554.07K) represents -2% of total liabilities (€2.36 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BIOCELTIX S.A. ZY -10 (2021–2025)
Financial flexibility index of BIOCELTIX S.A. ZY -10 from 2021 to 2025. Historical Financial Flexibility Index trend for BIOCELTIX S.A. ZY -10 across 5 annual periods. Explore XI3 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
BIOCELTIX S.A. ZY -10 Financial Flexibility Index by Year (2021–2025)
BIOCELTIX S.A. ZY -10 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for BIOCELTIX S.A. ZY -10. For the full cash flow conversion analysis, see cash flow conversion of BIOCELTIX S.A. ZY -10.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.24x | €-9.98 Million | €-11.95 Million | €2.36 Million | ▲ +16.0% |
| 2024 | -5.04x | €-17.32 Million | €-17.57 Million | €3.44 Million | ▲ +20.0% |
| 2023 | -6.30x | €-14.29 Million | €-14.75 Million | €2.27 Million | ▼ -109.5% |
| 2022 | -3.01x | €-7.52 Million | €-7.87 Million | €2.50 Million | ▼ -64.6% |
| 2021 | -1.83x | €-4.01 Million | €-4.02 Million | €2.20 Million | — |